To include your compound in the COVID-19 Resource Center, submit it here.

Antibacterial play Entasis raises $50M series B

Entasis Therapeutics Inc. (Waltham, Mass.) raised $50 million in a series B round

Read the full 130 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE